PARVAC VACCINE

국가: 오스트레일리아

언어: 영어

출처: APVMA (Australian Pesticides and Veterinary Medicines Authority)

유효 성분:

CANINE PARVOVIRUS (INACTIVATED); THIOMERSAL

제공처:

ZOETIS AUSTRALIA PTY LTD

INN (International Name):

canine parvovirus

약제 형태:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

구성:

CANINE PARVOVIRUS (INACTIVATED) VACCINE-VIRAL Active 0.0 U; THIOMERSAL MERCURY Other 0.1 mg/ml

패키지 단위:

10mL Vial; 1mL Vial; 20 x 1mL syringes; 20 x 1mL Vials; 25 x 1mL Syringes; 25 x 1mL Vials

수업:

VM - Veterinary Medicine

Manufactured by:

ZOETIS AUSTRALIA

치료 그룹:

DOG | BITCH | CASTRATE | PUPPY

치료 영역:

IMMUNOTHERAPY

치료 징후:

CANINE PARVOVIRUS | PARVOVIRUS

제품 요약:

Poison schedule: 0; Withholding period: WHP: N/A; Host/pest details: DOG: [CANINE PARVOVIRUS]; Poison schedule: 0; Withholding period: ; Host/pest details: DOG: [CANINE PARVOVIRUS]; For the immunisation of dogs against canine parvovirus.This product should not be use in dogs when they are: incubating an infectious disease; seriously debilitated by another infectious disease, parasitic infestation or malnutrition; or under treatment with immunosuppressive drugs.

승인 상태:

Registered

승인 날짜:

2023-07-01

환자 정보 전단

Product Name:
APVMA Approval No:
PARVAC VACCINE
51777 / 129907
Label Name:
PARVAC VACCINE
Signal Headings:
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
Canine Parvovirus (inactivated) ≥ 10^5.0 TCID50/mL
0.1 mg/mL Thiomersal as preservative.
Claims:
For the immunisation of dogs against canine parvovirus.
Net Contents:
20 x 1mL Vials
20 x 1mL Syringes
10mL Vial
1mL Vial
25 x 1mL Vials
25 x 1mL Syringes
Directions for Use:
Restraints:
Contraindications:
This product should not be used in dogs when they are:
1. incubating an infectious disease;
2. seriously debilitated by another infectious disease, parasitic
infestation or malnutrition; or
3. under treatment with immunosuppressive drugs.
Precautions:
Side Effects:
As Parvac Vaccine is an inactivated vaccine, untoward systemic effects
are very rare and
the vaccine may be used in pregnant bitches. However, the adjuvant
will cause a temporary
local reaction at the site of injection, though this is seldom
visible. Careful palpation may
reveal a small fibrous nodule at the site of vaccination in some dogs
about one week post-
vaccination. This nodule will regress, becoming impalpable within two
to six weeks. In a
very few small, smooth-coated dogs, such a nodule may be visible for a
limited period. RLP APPROVED
Dosage and
Administration:
Parvac Vaccine is an adjuvanted vaccine; there may be settling of the
adjuvant after
storage but the material is easily resuspended by inversion of the
syringe or bottle.
Use all product within 12 hours of opening.
The vaccine is injected subcutaneously.
A 1 mL dose is recommended for dogs of all ages.
Gentle massage at the site of injection will help to disperse the
vaccine.
Shake gently before use.
REMOVAL OF THE NEEDLE COVER
Do not attempt to screw off needle cover
Ease off by twisting syringe to and fro gently
General Directions:
Parvac Vaccine is an inactivated vaccine prepared from ≥ 10^5.0
TCID50/mL canine
parvovirus grown aseptically in a continuous cell line. An aluminium
salt is included to
enhance the response to vacc

제품 특성 요약

PRODUCT NAME: PARVAC® VACCINE
PAGE: 1 OF 6
THIS VERSION ISSUED: 19 FEBRUARY 2015
SAFETY DATA SHEET
Issued by: Zoetis Australia Pty Ltd
Phone: [phone]
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA
SECTION 1 - IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND SUPPLIER
ZOETIS AUSTRALIA PTY LTD
ABN 94 156 476 425
Level 6, 5 Rider Blvd
Rhodes NSW 2138 AUSTRALIA
Tel: [phone]
Fax: [phone]
Email: [e-mail]
PRODUCT IDENTIFIER:
PARVAC® VACCINE
OTHER NAMES:
None.
APVMA APPROVAL NO:
51777
CHEMICAL FAMILY:
Inactivated Canine Parvovirus Vaccine in an aqueous medium.
RECOMMENDED USE:
For the control of parvovirus in dogs by injection.
RESTRICTIONS ON USE
For veterinary use only.
EMERGENCY PHONE:
1800 814 883 (ALL HOURS)
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to Australian Dangerous Goods (ADG)
Code, IATA or IMDG/IMSBC criteria.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S23, S25, S36. Do not breathe mists. Avoid contact with eyes. Wear
suitable protective clothing.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good according to Australian Dangerous
Goods (ADG)
Code, IATA or IMDG/IMSBC criteria.
GHS LABEL ELEMENTS: NONE
SIGNAL WORD: NONE – NOT HAZARDOUS.
GHS CLASSIFICATION: NOT HAZARDOUS.
PREVENTION
P102: Keep out of reach of children.
P262: Do not get in eyes, on skin, or on clothing.
P281: Use personal protective equipment as required.
RESPONSE
P353: Rinse skin or shower with water.
P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P370+P378: Not combustible. Use extinguishing media suited to burning
materials.
STORAGE
P410: Protect from sunlight.
P411: Store at temperatures preferably between 2 and 8°C, but do not
freeze.
P403+P233: Store in a well-ventilated place. Keep container tightly
closed.
DISPOSAL
P501: Dispose of small quantities and empty containers by wrapping
with pa